arrow
P

Parveen Shiraz

stanford university
H指数:20
被引数:1,819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy

复发/难治性多发性骨髓瘤患者接受BCMA靶向CAR-T治疗后BCMA表达动力学

2026-04-040
OA
Superior Chronic Graft-versus-Host Disease–Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation

与他克莫司/甲氨蝶呤相比,在骨髓清除性HLA匹配的异基因造血细胞移植中,移植后环磷酰胺具有更优的慢性移植物抗宿主病无病生存率

2026-03-250
OAAI
Non-Myeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS

非清髓性预处理联合抗-CD117抗体Briquilimab在具有高风险AML和MDS的老年患者中的应用

Blood
IF23.1
2026-03-090
PRE
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

Axicabtagene ciloleucel联合利妥昔单抗治疗难治性大b细胞淋巴瘤: 2期单臂ZUMA-14试验

2026-01-050
OAAI
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort

异基因造血细胞移植在未达完全缓解的急性髓系白血病中的应用:当代队列的结局与预后因素

2025-11-250
OAAI
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024

抗CD38单克隆抗体疗法对来自社区和学术肿瘤学实践的新诊断多发性骨髓瘤(NDMM)患者干细胞动员产量的影响:单中心、真实世界数据2021-2024

2025-08-270
PRE
Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy

自体干细胞加强治疗后BCMA-CAR T细胞治疗患者的IEC-HS致命复发

2025-05-140
OA
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma
2024-10-090
OAAI
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-speci fi c expansion and toxicity
2024-06-258
OAAI
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
LEUKEMIA
IF13.4
2024-03-153
OA
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD
2024-02-284
OAAI
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era

异基因造血细胞移植治疗成人急性淋巴细胞白血病

2022-08-014
OAAI
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report
2022-04-0114
OAAI
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients
2021-10-2738
OA
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia
2021-08-2027
OA
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

CD19和CD22双重靶向CAR T细胞治疗复发性或难治性b细胞恶性肿瘤的1期临床试验

2021-07-26360
OAAI